Latest news with #ZDS-Varenicline
Business Standard
5 days ago
- Health
- Business Standard
Zydus receives NOC from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg
Zydus Lifesciences (including its subsidiaries/ affiliates, hereafter referred to as Zydus) has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg. This is the group's first NOC approval in Canada. Varenicline is used as an aid in smoking cessation. It is a partial nicotinic acetylcholine receptor agonist, designed to partially activate this system while displacing nicotine at its sites of action in the brain. ZDS-Varenicline tablets will be produced at Zydus Lifescience, SEZ, Ahmedabad. Varenicline tablets had annual sales of 15 mn Canadian dollar in Canada (IQVIA MAT December 2024).
News18
5 days ago
- Health
- News18
Zydus gets NOC from Health Canada for smoking cessation aid
Agency: PTI New Delhi, Aug 7 (PTI) Zydus Lifesciences on Thursday said it has received a no objection certificate (NOC) from Health Canada for a product used to help quit smoking. The company has received NOC for ZDS-Varenicline tablets (0.5 &1 mg), Zydus Lifesciences said in a statement. Varenicline is used as an aid in smoking cessation. It is a partial nicotinic acetylcholine receptor agonist, designed to partially activate this system while displacing nicotine at its sites of action in the brain. ZDS-Varenicline tablets will be produced at Zydus Lifescience Ltd, SEZ, Ahmedabad, the drugmaker said. As per IQVIA MAT December 2024 data, Varenicline tablets had annual sales of CAD 15 million in the Canadian market. PTI MSS MSS SHW view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
